Finance

Beta
Ask
Lists
2348:HKG
Dawnrays Pharmaceutical (Holdings) Ltd
HK$1.04
0.00%
(0.00) 1D
Jun 22, 4:00:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2348...
Open
HK$1.04
High
HK$1.04
Low
HK$1.04
Mkt. cap
1.57B
Avg. vol.
102.39K
Volume
164.00K
Dividend
6.06%
Quarterly dividend
HK$0.02
Ex-dividend date
May 27, 2026
P/E ratio
6.31
52-wk high
HK$1.47
52-wk low
HK$1.00
EPS
HK$0.16
Shares outstanding
1.51B
No. of employees
1K
Open
HK$1.04
High
HK$1.04
Low
HK$1.04
Mkt. cap
1.57B
Avg. vol.
102.39K
Volume
164.00K
Dividend
6.06%
Quarterly dividend
HK$0.02
Ex-dividend date
May 27, 2026
P/E ratio
6.31
52-wk high
HK$1.47
52-wk low
HK$1.00
EPS
HK$0.16
Shares outstanding
1.51B
No. of employees
1K
News stories
From sources across the web
About Dawnrays Pharmaceutical (Holdings) Ltd
CEO-
Employees1.08K
Founded1995
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
315.21M
315.21M
300.22M
300.22M
Cost of goods sold
170.34M
170.34M
166.39M
166.39M
Cost of revenue
170.34M
170.34M
166.39M
166.39M
Research and development expenses
28.41M
28.41M
13.33M
13.33M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
62.16M
62.16M
59.98M
59.98M
Operating expense
90.80M
90.80M
74.19M
74.19M
Total operating expenses
261.13M
261.13M
240.59M
240.59M
Operating income
54.08M
54.08M
59.63M
59.63M
Other non operating income
4.03M
4.03M
5.90M
5.90M
EBT including unusual items
65.16M
65.16M
59.65M
59.65M
EBT excluding unusual items
67.11M
67.11M
71.04M
71.04M
Income tax expense
14.30M
14.30M
4.95M
4.95M
Effective tax rate
21.95%
21.95%
8.30%
8.30%
Other operating expenses
227.50K
227.50K
886.50K
886.50K
Net income
52.29M
52.29M
54.70M
54.70M
Net profit margin
16.59%
16.59%
18.22%
18.22%
Earnings per share
-
-
-
-
Interest and investment income
8.62M
8.62M
6.85M
6.85M
Interest expense
-157.00K
-157.00K
-91.00K
-91.00K
Net interest expenses
8.46M
8.46M
6.76M
6.76M
Depreciation and amortization charges
-
-
-
-
EBITDA
78.30M
78.30M
93.52M
93.52M
Gain or loss from assets sale
474.00K
474.00K
307.50K
307.50K
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more